Prostate cancer
Results
Phase 3
This trial was looking at a drug called zibotentan alongside docetaxel for men with prostate cancer that had spread to the bones. The trial was for men who had prostate cancer that was no longer responding to hormone therapy.
Recruitment start: 24 January 2008
Recruitment end: 30 April 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Heather Payne
AstraZeneca
Last reviewed: 28 April 2015
CRUK internal database number: 3990
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
